相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association
Solana Alculumbre et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2G2019S-Parkinson's disease
Diana Luz Juarez-Flores et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Type I Interferons, Autophagy and Host Metabolism in Leprosy
Thiago Gomes Toledo Pinto et al.
FRONTIERS IN IMMUNOLOGY (2018)
Plasma Cell Differentiation Pathways in Systemic Lupus erythematosus
Susan Malkiel et al.
FRONTIERS IN IMMUNOLOGY (2018)
LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection
Weiwei Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Peripheral CD19hi B cells exhibit activated phenotype and functionality in promoting IgG and IgM production in human autoimmune diseases
Zhicui Liu et al.
SCIENTIFIC REPORTS (2017)
Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses
Makoto Kubo et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway
Hong-Ki Min et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
LRRK2 dephosphorylation increases its ubiquitination
Jing Zhao et al.
BIOCHEMICAL JOURNAL (2015)
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
Joao P. L. Daher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Commensal bacteria direct selective cargo sorting to promote symbiosis
Qin Zhang et al.
NATURE IMMUNOLOGY (2015)
Alternative to LRRK2-IN-1 for Pharmacological Studies of Parkinson's Disease
Kyoko Koshibu et al.
PHARMACOLOGY (2015)
Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China
D. Wang et al.
GENES AND IMMUNITY (2015)
Prevalence of Cancer in Parkinson's Disease Related to R1441G and G2019S Mutations in LRRK2
Javier Ruiz-Martinez et al.
MOVEMENT DISORDERS (2014)
Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis
Hannah Beckwith et al.
NEPHRON CLINICAL PRACTICE (2014)
The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson's Disease
Hardy J. Rideout et al.
NEUROCHEMICAL RESEARCH (2014)
Genetic susceptibility to SLE: Recent progress from GWAS
Yong Cui et al.
JOURNAL OF AUTOIMMUNITY (2013)
GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
Alastair D. Reith et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The role of LRRK2 in inflammatory bowel disease
Zhihua Liu et al.
CELL RESEARCH (2012)
Germinal center selection and the development of memory B and plasma cells
Mark J. Shlomchik et al.
IMMUNOLOGICAL REVIEWS (2012)
Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson's Disease-Related Toxicity in Human Neurons
Nigel Ramsden et al.
ACS CHEMICAL BIOLOGY (2011)
Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus
Sebastian Dolff et al.
CLINICAL IMMUNOLOGY (2011)
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Zhihua Liu et al.
NATURE IMMUNOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mechanisms of B cell autoimmunity in SLE
Thomas Doerner et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen
Tatsunori Maekawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The complement system in systemic autoimmune disease
Min Chen et al.
JOURNAL OF AUTOIMMUNITY (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
R Martínez et al.
Journal of Translational Medicine (2010)
Emerging roles of TLR7 and TLR9 in murine SLE
Marie-Laure Santiago-Raber et al.
JOURNAL OF AUTOIMMUNITY (2009)
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons
Westley H. Reeves et al.
TRENDS IN IMMUNOLOGY (2009)
A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE
Matilda W. Nicholas et al.
CLINICAL IMMUNOLOGY (2008)
High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus
T. B. Niewold et al.
GENES AND IMMUNITY (2007)
Single and combined deletions of the NTAL/LAB and LAT adaptors minimally affect B-cell development and function
Y Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Development and selection of marginal zone B cells
T Lopes-Carvalho et al.
IMMUNOLOGICAL REVIEWS (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Expansion of CD19hiCD21lo/neg B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia
K Warnatz et al.
IMMUNOBIOLOGY (2002)
分享论文
